Omicron Subvariants Escape Antibodies Elicited by Vaccination and BA.2.2 Infection
![](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/4833616.jpg?fit=800%2C533&ssl=1)
Lin Yao et al. The BA.1, BA.2, and BA.3 omicron subvariants of SARS-CoV-2 showed similar but substantial resistance to vaccine-induced and infection-induced serum neutralising activity.
Dengvaxia Controversy: Impact on Vaccine Hesitancy
![](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/zhpqbiav9qc.jpg?fit=800%2C534&ssl=1)
Khunsha Fatima, Najah Irfan Syed … The quest for a suitable vaccine for dengue has been ongoing for the last six decades. In one such effort, Sanofi, one of the biggest multinational pharmaceutical companies, developed the world’s first dengue vaccine – Dengvaxia. The vaccine is now approved in 19 countries and was used in vaccination […]
How Effective Are Covid Vaccines, Really?
![](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/5926664.jpg?fit=800%2C450&ssl=1)
Swiss Policy Research Magic potion or snake oil? An honest look at the international data. … Thus, while the risk/benefit ratio may still be positive in senior citizens and other risk groups (based on current evidence), this does not appear to be the case in healthy young adults and children. Danish professor in global health […]
Self-reported Outcomes, Choices and Discrimination Among a Global COVID-19 Unvaccinated Cohort
![Person Holding Syringe](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/3952224.jpg?fit=719%2C1024&ssl=1)
Robert Verkerk, Christof Plothe, Naseeba Kathrada, Katarina Lindley … a UK citizen-led cooperative, the Control Group Cooperative (CGC) (vaxcontrolgroup.com), was formed in July 2021 to represent the interests of individuals and families around the world who have chosen to not receive COVID-19 ‘vaccines.’ Among the aims of the CGC is to evaluate long-term health outcomes […]
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
![Close-Up Shot of a Covid Vaccine](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/6804927.jpg?fit=800%2C534&ssl=1)
Yair Goldberg et al. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides natural immunity against reinfection. Recent studies have shown waning of the immunity provided by the BNT162b2 vaccine. The time course of natural and hybrid immunity is unknown.
Let the EVIDENCE Speak: Did Vaccines Save Us?
![](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/1884758-1.jpg?fit=800%2C480&ssl=1)
Vax Info Start Here There is a perception out there that vaccines saved us from the deadly diseases of the 19th and 20th centuries. But did they? Please review the evidence below. You will see that in developed nations, mortality from these diseases declined dramatically before vaccines came in, with the trend heading downward (smallpox and polio […]
The Boosted Deaths in Canada Just Surpassed the Fully Vaccinated
![person holding white plastic bottle](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/coh3j5lqdyo.jpg?fit=800%2C534&ssl=1)
Sheldon Yakiwchuk Experts wanting to Mandate on the exact same week that Health Canada Numbers report that the Boosted Mortality just surpassed the Fully Vaccinated…
Long COVID Risk Falls Only Slightly After Vaccination, Huge Study Shows
![3 clear glass bottles on table](https://i0.wp.com/canadahealthalliance.org/wp-content/uploads/2022/06/qsuou3vatf4.jpg?fit=800%2C450&ssl=1)
Sara Reardon Vaccination against SARS-CoV-2 lowers the risk of long COVID after infection by only about 15%, according to a study of more than 13 million people1. That’s the largest cohort that has yet been used to examine how much vaccines protect against the condition, but it is unlikely to end the uncertainty.